期刊文献+

食管癌组织TGIF表达的意义 被引量:3

Expression of TGIF in esophageal carcinoma and its clinicopathological features
下载PDF
导出
摘要 目的:探讨TGIF(TG interacting factor)蛋白在食管癌中的表达水平及其临床病理意义. 方法:应用免疫组织化学SP法,对32例食管癌的活检和手术切除标本进行抗人TGIF抗体免疫组织化学染色,检测癌组织和癌旁组织TGIF的表达,并分析TGIF的表达与食管癌临床病理特征之间的关系. 结果:TGIF在食管黏膜鳞状上皮和食管癌组织中阳性率分别为60.0%和71.2%,但后者以中度-强阳性为主.TGIF 蛋白在食管癌组织中的表达水平明显高于正常食管黏膜鳞状上皮(P=0.036),但与性别、肿瘤的分化、浸润深度及淋巴结的转移无关. 结论:TGIF通过抑制TGF-β和视黄醛促进食管癌的发生与发展. AIM: To investigate the expression level of TG interacting factor (TGIF) in esophageal carcinomas, and the correlation between TGIF and clinicopathological features of esophageal carcinoma. METHODS: A total of 32 specimens of esophageal carcinoma were investigated by immunohistochemical staining with a polyclonal antibody against TGIF. The expression of TGIF in esophageal carcinoma was detected and the relationship between the expression of TGIF and clinico-patho-logical features of esophageal carcinoma was analyzed. RESULTS: The positive rates of TGIF in normal esophageal squamous epithelium and esophageal carcinoma were 60% and 71.2%, respectively, but the latter had stronger intensity staining. The expression level of TGIF in esophageal carcinoma was higher than that in normal esophageal squamous epithelium (P=0.036), but had no correlation with gender, depth of invasion, tumor grade and lymph node metastasis. CONCLUSION: TGIF is a possible oncogene, and it may promote the progression of esophageal carcinomas via inhibiting both the TGF-β and retinoid signaling pathways.
出处 《世界华人消化杂志》 CAS 2004年第8期1766-1768,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献16

二级参考文献39

  • 1Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-1065 被引量:1
  • 2Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshan K,Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH.A cell cycle regulator potentially involved in genes of many tumor types. Science 1994;264:436-440 被引量:1
  • 3Serrano M, Hanno GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin-CDK4. Nature 1993;366:704-707 被引量:1
  • 4Hunter T, Pines J. Cyclins and cancer Ⅱ: cyclin D and CDK inhibitor come of age. Cell 1994;79:573-582 被引量:1
  • 5Marx J. New tumor suppressor may rival p53. Science 1994;264:344-345 被引量:1
  • 6Pande P, Mathur M, Shukla NK, Ralhan R. pRb and p16 protein alterationsin human oral tumorigenesis. Oral Oncol 1998;34:396-403 被引量:1
  • 7Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J, Kaye FJ. Immunohistochemical analysis of the p16INK4 cyclindependent kinase inhibitor in malingnant mesothelioma. J Natl Cancer Inst 1995;58:1870-1875 被引量:1
  • 8Reed JA, Loganzo F Jr, Shea CR, Walker GJ, Flores JF, Glendening JW, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW.Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995;55:2713-2718 被引量:1
  • 9Kinoshita I, Dosaka-Akita H, Mishina T,Akie K, Nishi M,Hiroumi H, Hommura F, Kawakmi Y. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1996;56:5557-5562 被引量:1
  • 10Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ.Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-1354 被引量:1

共引文献30

同被引文献41

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部